Autopsy report · NCT05499780

Study on Performance and Safety of Sentinox in the Prevention of Acute Respiratory Infections (ARI)

“Difficulty in enrolment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 10 months before it stopped.
• 144 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

APR Applied Pharma Research s.a.

Sponsor type

University, hospital or other

Conditions

Healthy Volunteers

Interventions

Sentinox

Participants

144

Sites

1

Countries

Italy

Trials that died the same way

• Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder
  “difficulty in the enrolment” (98% match in meaning)
• Adjunctive Vitamin D in the Treatment of Non-remitted Depression
  “Difficulties with subject enrolment.” (87% match in meaning)
• FFP Versus PCC in Intracranial Hemorrhage
  “Lack of enrolment” (79% match in meaning)
• Enzyme Replacement Therapy in Fabry Disease
  “Difficulties in the patient's enrolment” (75% match in meaning)
• Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
  “Poor enrolment” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.